Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 18035
Country/Region: Namibia
Year: 2017
Main Partner: University of Washington
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $7,293,400 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $125,000
Care: Pediatric Care and Support (PDCS) $80,000
Strategic Information (HVSI) $250,000
Health Systems Strengthening (OHSS) $690,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,323,400
Testing: HIV Testing and Counseling (HVCT) $400,000
Sexual Prevention: Other Sexual Prevention (HVOP) $1,350,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $175,000
Treatment: Adult Treatment (HTXS) $2,700,000
Treatment: Pediatric Treatment (PDTX) $200,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 6
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 10
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 4
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 20
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 80
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 20
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 50
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 170
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 40
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 100
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 40
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 200
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 140
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 260
GEND_GBV Number of people receiving post-GBV care 2018 400
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 95,062
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 1,567
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 2,764
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 5,198
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 178
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 140
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 281
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 386
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 42
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 47
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 576
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 193
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 753
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 1,247
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 1,645
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 887
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 634
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 341
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 3,961
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 2,134
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 4,968
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 7
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 18
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 47
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 300
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 418
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 1,515
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 3,544
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: Unknown Age, Negative 2018 11,256
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 63
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 68
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 1,521
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 1,648
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 2,737
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 1,480
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 23,042
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 12,410
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 55
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 124
HTS_TST Service Delivery Point by Agg Age (Facility) VMMC: 15+, Negative 2018 913
HTS_TST Sum of Test Result disaggregates 2018 5,948
HTS_TST_POS By Test Result: Positive 2018 5,948
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 167
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 354
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 73
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 87
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 118
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 150
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 83
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 214
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 121
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 123
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 35
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 19
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 267
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 626
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: Unknown Age, Positive 2018 642
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 7
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 9
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 218
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 238
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 144
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 72
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,162
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 622
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 49
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 105
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: 15+, Positive 2018 35
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,583
PMTCT_ART New on ART 2018 1,219
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 3,802
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 24,825
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 3,769
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 821
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,867
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 52
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 29
PMTCT_STAT By Age (Numerator): 15-19 2018 1,692
PMTCT_STAT By Age (Numerator): 20-24 2018 3,281
PMTCT_STAT By Age (Numerator): 25-49 2018 6,279
PMTCT_STAT By Number of known positives: 15-19 2018 95
PMTCT_STAT By Number of known positives: 20-24 2018 350
PMTCT_STAT By Number of known positives: 25-49 2018 727
PMTCT_STAT By Number of known positives: Unknown Age 2018 1,675
PMTCT_STAT By Number of new negative: 15-19 2018 1,567
PMTCT_STAT By Number of new negative: 20-24 2018 2,764
PMTCT_STAT By Number of new negative: 25-49 2018 5,198
PMTCT_STAT By Number of new negative: Unknown Age 2018 11,254
PMTCT_STAT By Number of new positives: 15-19 2018 30
PMTCT_STAT By Number of new positives: 20-24 2018 167
PMTCT_STAT By Number of new positives: 25-49 2018 354
PMTCT_STAT By Number of new positives: Unknown Age 2018 644
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 24,825
PMTCT_STAT_den By Age (Denominator): <15-19 2018 1,814
PMTCT_STAT_den By Age (Denominator): 20-24 2018 3,450
PMTCT_STAT_den By Age (Denominator): 25-49 2018 6,580
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 14,311
PP_PREV Age/sex: 10-14 Female 2018 1,956
PP_PREV Age/sex: 10-14 Male 2018 1,956
PP_PREV Age/sex: 15-19 Female 2018 4,889
PP_PREV Age/sex: 15-19 Male 2018 4,889
PP_PREV Age/sex: 20-24 Female 2018 2,935
PP_PREV Age/sex: 20-24 Male 2018 978
PP_PREV Age/sex: 25-49 Female 2018 978
PP_PREV Age/sex: 25-49 Male 2018 978
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 40,118
PP_PREV Sum of Age/Sex disaggregates 2018 19,559
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,560
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,436
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 23
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 303
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 13
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 481
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 3,695
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 3,871
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 27
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 317
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 17
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 490
TX_CURR Age/Sex: 10-14 Female 2018 959
TX_CURR Age/Sex: 10-14 Male 2018 985
TX_CURR Age/Sex: 15-19 Female 2018 668
TX_CURR Age/Sex: 15-19 Male 2018 286
TX_CURR Age/Sex: 20-24 Female 2018 936
TX_CURR Age/Sex: 20-24 Male 2018 400
TX_CURR Age/Sex: 25-49 Female 2018 10,978
TX_CURR Age/Sex: 25-49 Male 2018 4,353
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,955
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,673
TX_CURR Aggregated Age/Sex: 15+ Female 2018 34,521
TX_CURR Aggregated Age/Sex: 15+ Male 2018 18,367
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 76,081
TX_CURR Sum of age/sex disaggregates 2018 954
TX_CURR Sum of Aggregated Age/Sex <15 2018 3,628
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 52,888
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 56,516
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 209
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 146
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 4,499
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 2,050
TX_NEW By Age/Sex: 10-14 Female 2018 66
TX_NEW By Age/Sex: 10-14 Male 2018 51
TX_NEW By Age/Sex: 15-19 Female 2018 111
TX_NEW By Age/Sex: 15-19 Male 2018 84
TX_NEW By Age/Sex: 20-24 Female 2018 736
TX_NEW By Age/Sex: 20-24 Male 2018 341
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 8,293
TX_NEW Sum of Age/Sex disaggregates 2018 1,389
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 6,904
TX_PVLS <15, Undocumented Test Indication, Female 2018 1,626
TX_PVLS <15, Undocumented Test Indication, Female 2018 1,911
TX_PVLS <15, Undocumented Test Indication, Male 2018 1,470
TX_PVLS <15, Undocumented Test Indication, Male 2018 1,727
TX_PVLS 15+, Undocumented Test Indication, Female 2018 24,919
TX_PVLS 15+, Undocumented Test Indication, Female 2018 29,319
TX_PVLS 15+, Undocumented Test Indication, Male 2018 13,016
TX_PVLS 15+, Undocumented Test Indication, Male 2018 15,312
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 48,269
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 41,032
TX_PVLS Undocumented Test Indication 2018 41,032
TX_PVLS Undocumented Test Indication 2018 48,269
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 223
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 160
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 3,576
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,831
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 5,790
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 7,348
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 298
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 211
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 4,537
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,302
VMMC_CIRC By Age: 10-14 2018 3,994
VMMC_CIRC By Age: 15-19 2018 3,994
VMMC_CIRC By Age: 20-24 2018 1,712
VMMC_CIRC By Age: 25-29 2018 1,142
VMMC_CIRC By Age: 30-49 2018 570
VMMC_CIRC By circumcision technique: Surgical VMMC 2018 11,412
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 11,412
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 11,412
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 9,700